Immunogenicity of BNT162b2 in children 6 months to under 5 years of age with previous SARS-CoV-2 infection, in the era of Omicron predominance-Reference-Cited by-同舟云学术

Immunogenicity of BNT162b2 in children 6 months to under 5 years of age with previous SARS-CoV-2 infection, in the era of Omicron predominance

Published:2023-12 Issue: Volume:15 Page:100367
ISSN:2590-1362
Container-title:Vaccine: X
language:en
Short-container-title:Vaccine: X

Author:

Nantanee Rapisa^ORCID,Jaru-Ampornpan Peera^ORCID,Chantasrisawad Napaporn^ORCID,Himananto Orawan^ORCID,Papakhee Supawan,Sophonphan Jiratchaya,Tawan Monta,Jupimai Thidarat,Anugulruengkitt Suvaporn^ORCID,Puthanakit Thanyawee^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference30 articles.

1. World Health Organization. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern 2021 [Available from: https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern. Accessed date February 26, 2023.

2. GISAID. Tracking of hCoV-19 Variants [Available from: https://gisaid.org/hcov19-variants/. Accessed date February 26, 2023.

3. Hodcroft EB. CoVariants: SARS-CoV-2 Mutations and Variants of Interest 2023 [Available from: https://covariants.org/. Accessed date February 26, 2023.

4. American Academy of Pediatrics and the Children’s Hospital Association. Children and COVID-19: State-Level Data Report 2023 [Available from: https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report/. Accessed date 5 March, 2023.

5. Pediatric Infection-Induced SARS-CoV-2 Seroprevalence Increases and Seroprevalence by Type of Clinical Care September 2021 to February 2022;Clarke;J Infect Dis,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global COVID-19 vaccination in infants and children: Effectiveness, safety, and challenges;Asian Pacific Journal of Allergy and Immunology;2023